surmount 1 tirzepatide SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, Presented today at #ECO2026 ⤵️
Description
Overall, it has shown to be a beneficial medication for those with type 2 diabetes and those seeking to lose weight
Diet is one factor in tirzepatide weight loss outcomes
Contact Your Doctor for These Symptoms If your symptoms persist or worsen beyond 48 hours, its time to reach out to your doctor
Over time, they may try weight-loss and diet programs or exercise nearly every day, yet still struggle with too many pounds
The study also assessed safety outcomes
